VTEQ News $VTEQ VeriTeQ Corporation and Establ
Post# of 73
VeriTeQ Corporation and Establishment Labs to Host Physician Conference in Europe Based on Demand for Motiva Breast Implants With Q Inside Safety Technology
GlobeNewswire - Wed Oct 15, 8:35AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the Company and its breast implant customer, Establishment Labs, S.A., ("EL" are hosting a physician conference in Salzburg, Austria on October 16, 2014, based on demand for EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM).
VeriTeQ Corporation Enters Agreement Providing Exclusive License of Multiple Patents From NC State University
GlobeNewswire - Thu Oct 09, 8:36AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has entered an agreement providing an exclusive license of multiple patents from North Carolina State University ("NCSU" . VeriTeQ will license 24 patents, which are the foundation for its FDA cleared Q Inside SmartMarker and OneDose products for radiation dosimetry.
VeriTeQ Receives First Order for 100 Units of Its New Q Inside Readers for Breast Implants
GlobeNewswire - Mon Sep 29, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has received an order for 100 units of its new Q Inside readers for breast implants. The Q Inside reader identifies VeriTeQ's Q Inside Safety Technology within breast implants and other medical devices.
Photo Release -- VeriTeQ Unveils New Q Inside Safety Technology Readers for Medical Device Identification
GlobeNewswire - Thu Sep 18, 9:34AM CDT
VeriTeQ Corporation ("VeriTeQ" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has unveiled two new readers used to identify VeriTeQ's Q Inside Safety Technology(TM) within implantable medical devices: the Q Inside Reader + and the Q Inside Reader XR +. The new readers are being launched based on demand from the breast implant industry.
VTEQ, Has Remained On Naked Short Lists 13 Consecutive Days
M2 - Wed Sep 17, 9:15AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Has Remained On the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. (OTC:VTEQ). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Over 1,000 Women Worldwide Have Now Received Motiva Breast Implants with VeriTeQ's Q Inside Safety Technology
Business Wire - Tue Sep 16, 8:39AM CDT
VeriTeQ Corporation ("VeriTeQ" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM). Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL" , featuring VeriTeQ's Q Inside Safety Technology(TM) can be safely and accurately identified from outside of the body in a physician's office.
VeriTeQ Corporation to Host Conference Call to Update Investors on Business and other Recent Events
Business Wire - Tue Aug 26, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it will host a conference call on Wednesday, September 3, 2014, at 10 a.m. ET, to update investors on the business and other recent events.
Adoption Increases for VeriTeQ's "Q Inside" Breast Implant Safety Technology
Business Wire - Thu Jul 17, 8:01AM CDT
--VeriTeQ's CEO Scott R. Silverman to present today at RedChip Companies' Global Online CEO Conference at 11 am ET
VeriTeQ Corporation Provides Business Update in New Interview With SmallCapVoice.com
GlobeNewswire - Wed Jul 16, 7:23AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with VeriTeQ Corporation ("VeriTeQ" or the "Company" (OTCQB:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, is now available. The interview with the Company's Chairman and CEO Scott R. Silverman can be heard at http://smallcapvoice.com/blog/7-15-14-smallca...-corp-vteq.
Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings
MASI: 23.23 (-0.11), HNSN: 0.98 (-0.01)
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Thu Jun 19, 10:53AM CDT
RedChip Companies, Inc. ("RedChip" , an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" TM) television program will feature three emerging growth companies on Fox Business nationwide on Thursday, June 19, 2014 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg U.K. Saturday, June 21, 2014 at 12:30 a.m. GMT; on Bloomberg Europe on Sunday, June 22, 2014 at 8:30 a.m. and 3:30 p.m. GMT; and on Bloomberg Asia on Sunday June 22, 2014 at 3:30 p.m. HKT.
VeriTeQ Appoints Former U.S. Ambassador Ned L. Siegel to its Board of Directors
Business Wire - Thu Jun 19, 10:38AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has appointed Ned L. Siegel, former U.S. Ambassador, to its Board of Directors, effective immediately. Ambassador Siegel will replace Michael Krawitz, the Company's Chief Legal and Financial Officer, as a director. Mr. Krawitz is stepping down from the Board to focus on his responsibilities as an executive of the Company and to enable the Company to increase its Board independence. Ambassador Siegel is a successful entrepreneur who brings more than 30 years of business and government experience to VeriTeQ, and will assist the Company with its strategic development and financing needs.
VeriTeQ Rebrands its "Q Inside SmartMarker" to Lead its Radiation Dosimetry Business; Q Inside Smart Marker is World's First Implantable Sensor Cleared by FDA to Measure Radiation Dose Directly at the Tumor Site
Business Wire - Thu Mar 27, 7:30AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it is rebranding its Q Inside SmartMarker to lead its radiation dosimetry business. Q Inside SmartMarker (previously known as DVS SmartMarker(R)) is the only FDA- cleared implantable radio frequency ("RF" radiation sensor that provides localization of a tumor and measures radiation dose at the tumor site. VeriTeQ's radiation dosimetry products have six FDA clearances and CE approvals, and the Company has over 100 patents, patents pending, and exclusive licenses.
VeriTeQ Delivers Q Inside Safety Technology Readers to Establishment Labs
Business Wire - Wed Mar 12, 8:29AM CDT
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has delivered Q Inside Safety Technology readers to its customer Establishment Labs, S.A. ("EL" . EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology are the world's first externally identifiable breast implants, and are now available to patients in the EU.
New Breast Implant Recall in the EU Prompts Need for VeriTeQ's Device Traceability Technology
Business Wire - Mon Feb 24, 7:31AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, today commented on the latest breast implant recall in the European Union. Breast implants manufactured by French company Cereplas are being recalled by The National Security Agency of Medicines and Health Products ("ANSM" due to concerns regarding sterilization and equipment used in production of the implants.
RJET: 11.73 (-0.63)
VeriTeQ's Partner Establishment Labs Gets Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Close-Up Media - Thu Feb 20, 11:36PM CST
VeriTeQ Corp., a provider of implantable medical device identification and radiation dose measurement technologies, said that its breast implant partner Establishment Labs ("EL" has received additional CE Mark approvals for its Motiva Implant Matrix VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix SilkSurface PLUS with Q Inside Safety Technology.
VeriTeQ Partner Establishment Labs Receives Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology
Business Wire - Tue Feb 18, 7:30AM CST
VeriTeQ Corporation ("VeriTeQ" or "Company" (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that its breast implant partner Establishment Labs, S.A. ("EL" has received additional CE Mark approvals for its Motiva Implant Matrix(R) VelvetSurface PLUS with Q Inside Safety Technology and Motiva Implant Matrix(R) SilkSurface PLUS with Q Inside Safety Technology. EL's Motiva Implant Matrix product line with VeriTeQ's Q Inside Safety Technology offers the world's first externally identifiable breast implant.